Published in

SAGE Publications, Annals of Clinical Biochemistry, 1(52), p. 183-183, 2014

DOI: 10.1177/0004563214561853

Oxford University Press (OUP), The Journal of Clinical Endocrinology & Metabolism, 12(99), p. 4546-4554

DOI: 10.1210/jc.2014-1971

Links

Tools

Export citation

Search in Google Scholar

Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO